Terms: = Ovarian cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Clinical Outcome
4 results:
1. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.
Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L
Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864
[No Abstract] [Full Text] [Related]
2. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
Zhang Q; Zhou W; Yu S; Ju Y; To SKY; Wong AST; Jiao Y; Poon TCW; Tam KY; Lee LTO
Oncogene; 2021 Jan; 40(1):97-111. PubMed ID: 33082557
[TBL] [Abstract] [Full Text] [Related]
3. Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Schilder RJ; Brady WE; Lankes HA; Fiorica JV; Shahin MS; Zhou XC; Mannel RS; Pathak HB; Hu W; Alpaugh RK; Sood AK; Godwin AK
Gynecol Oncol; 2012 Oct; 127(1):70-4. PubMed ID: 22710075
[TBL] [Abstract] [Full Text] [Related]
4. Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.
Trinh XB; Tjalma WA; Dirix LY; Vermeulen PB; Peeters DJ; Bachvarov D; Plante M; Berns EM; Helleman J; Van Laere SJ; van Dam PA
PLoS One; 2011; 6(7):e22469. PubMed ID: 21799864
[TBL] [Abstract] [Full Text] [Related]
